Specifications table {#s0005}
====================

Subject area*Dermatology*Organism/cell*Homo sapiens*More specific subject area*Lesional and non-lesional skin samples from patients with chronic cutaneous lupus erythematosus (CCLE)*How data was acquired*Affymetrix GeneChip HG-U95set*Data format*Raw data: CEL files*Experimental factors*Comparison of lesional and non-lesional skin from CCLE patients*Experimental features*We performed both unsupervised and supervised analysis and established differentially expressed genes (DEGs) between lesional and non-lesional skin of CCLE patients. The DEGs were then analyzed by pathway and biological processes-based enrichment analyses via DAVID and Metacore.*Data source location*Patients diagnosed with CCLE, and more specifically DLE, were recruited into the study from the Dermatology Outpatient Clinic of New York Presbyterian Hospital, Cornell University.*Data accessibility*Data is available with this article*

Value of the data {#s0010}
=================

•The CEL files included with this document will allow access to genome-wide transcriptional profiling data from lesional and non-lesional skin of CCLE patients, for further analysis.•The data fill a major gap in knowledge regarding changes that underlie skin specific manifestations in cutaneous lupus.•The data can be used to link transcriptional profiling data to functional and pathway based analyses to clarify underlying mechanisms of disease.

1. Data, materials and methods {#s0015}
==============================

The raw data files (CEL files) that were used in the analysis and interpretation in [@bib4] are available in [Supplementary information](#s0020){ref-type="fn"}.

Sample IDs are:LE1001DLE1001NLE1003DLE1003NLE1006DLE1008DLE1009DLE1009NLE1010DLE1010N

Abbreviations:LE: chronic cutaneous lupus erythematosusN: non-lesional skinD: lesional skin

Affymetrix Human genome U95 set GeneChip was used according to manufacturer׳s protocols to analyze gene expression from 6 lesional and 4 non-lesional skin samples of CCLE patients. Expression Console software (Affymetrix) with MAS5 data processing was used to assess the quality of every CEL file in the dataset. Samples determined to be outliers with low quality data and very low percentage present called were removed from the dataset. Default parameters were used to import the gene expression data to Partek Genomics Suite v6.6. Raw data preprocessing was achieved through RMA, including log2 transformation, quantile normalization, background subtraction and median polish probeset summarization to scale mean expression of all 10 arrays. We re-examined QC criteria for our dataset in Partek and found no outliers. Both unbiased and supervised hierarchical cluster analysis were performed and DEGs established. Functional annotation and pathway analysis were performed by standard enrichment analysis via DAVID and Metacore. Further details can be found in the materials and methods and supplementary materials and methods sections [@bib4].

Supplementary materials {#s0025}
=======================

Supplementary data
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Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.dib.2015.02.024](http://dx.doi.org/10.1016/j.dib.2015.02.024){#ir0005}.
